I
WST icon

IMPACTfolio’s West Pharmaceutical WST Stock Holding History

IMPACTfolio’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-781
Closed -$236K – 54
2022
Q2 		$236K Buy
781
+4
+0.5% +$1.3K 0.22% 40
2022
Q1 		$319K Buy
777
+87
+13% +$34.1K 0.24% 35
2021
Q4 		$324K Buy
+690
New +$297K 0.28% 35

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMPACTfolio's WST Position: Q3 2022 in Review

IMPACTfolio sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 781 shares — an estimated $236K sold.

IMPACTfolio first reported a position in WST in Q4 2021 and held it in 3 quarters. The position peaked at $324K in Q4 2021. 638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • IMPACTfolio reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • IMPACTfolio sold 781 West Pharmaceutical shares in Q3 2022, an estimated $236K.
  • IMPACTfolio first reported a position in West Pharmaceutical in Q4 2021 and held it in 3 quarters.
  • IMPACTfolio's West Pharmaceutical position peaked at $324K in Q4 2021.
  • 638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on IMPACTfolio's 13F filing for Q3 2022, filed 5 Oct 2022.